Results 51 to 60 of about 2,263 (160)

Premenstrual syndrome: possibility of therapy [PDF]

open access: yesГинекология, 2014
Premenstrual syndrome includes more than 200 variety of symptoms and requires more detailed examination to rule out serious medical conditions. The problem of treatment of premenstrual syndrome to be a return of women of reproductive age to normal life ...
I A Kulikov, T V Ovsyannikova
doaj  

Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database

open access: yesOpen Access Journal of Contraception, 2018
David Madigan, Jennifer Shin Department of Statistics, Columbia University, New York, NY, USA Introduction: Substantial evidence suggests that drospirenone-containing oral contraceptives may cause a higher risk of venous thrombotic events than earlier ...
Madigan D, Shin J
doaj  

The efficacy of 17β-estradiol and low dosed drospirenone use in postmenopausal women (literature review) [PDF]

open access: yesГинекология, 2015
Vasomotor symptoms, including hot flushes (HF), are the most common symptoms of menopause, requiring treatment with estrogen and/or progestogen. Recent international guidelines recognize the need to use the lowest effective dose of hormone replacement ...
E N Andreeva   +2 more
doaj  

Treatment of dermopathy in patients with polycystic ovary syndrome (clinical lecture)

open access: yesМедицинский совет, 2015
The article summarizes the current aspects of the pathogenesis of PCOS and hyperandrogenism mechanisms. The treatment of dermopathy using COC and other androgen receptor blockers is substantiated.
M. A. Gevorkyan   +2 more
doaj   +1 more source

Effect of menopausal hormone therapy on the skin as a component of healthy aging

open access: yesМедицинский совет, 2018
Healthy aging (anti-aging) involves the prevention of illness and disability, keeping mental and physical activity in tip-top shape, maintaining the meaning and purpose of life. Women refuse to age and want to look younger as long as possible.
S. V. Yureneva, L. M. Ilyina
doaj   +1 more source

Characteristics of uterine bleeding associated with an oral contraceptive containing drospirenone in combination with estetrol: A multicenter observational study

open access: yesГинекология
Background. An unfavorable bleeding pattern is a common reason for refusing to continue hormonal contraception. Aim. To evaluate the characteristics of uterine bleeding when using a new combined oral contraceptive (COC) containing estetrol and ...
Irina V. Kuznetsova   +1 more
doaj   +1 more source

Folate-containing antiandrogen oral contraceptives: dermatological aspects [PDF]

open access: yesГинекология, 2016
Examined are the biological effects of folic acid and pathological conditions developing in the case of folate deficiency. Particular attention is paid to the application of innovative dermatological aspects of oral contraceptives with antiandrogenic ...
S A Monakhov
doaj  

Efficacy and safety of ultralow doses of drospirenone and 17β-estradiol in postmenopausal women meta-analysis

open access: yesМедицинский совет, 2018
Vasomotor symptoms, including hot flashes (HF), are the most common symptoms of the menopause, which require the hormone replacement therapy with estrogens and/or progestogens. Recent international clinical guidelines recognize the need to use the lowest
O. R. Grigoryan
doaj   +1 more source

HRT and extragenital diseases: 2013 evidence

open access: yesМедицинский совет, 2013
With the environmental situation getting worse every year, unhealthy diet, adynamia and sleep-wake cycle imbalance, the health of Russian people is deteriorating. The incidence of diseases of civilization has been steadily increasing: today, they are the
V. E. Radzinskiy, R. Yu. Yeremichev
doaj   +1 more source

Drospirenone/ethinyl estradiol 3 mg/20 µg (24/4 day regimen): hormonal contraceptive choices – use of a fourth-generation progestin

open access: yesPatient Preference and Adherence, 2009
Gloria Bachmann, Sharon KopaczWomen’s Health Institute, University of Medicine and Dentistry of New Jersey, USAAbstract: The combined oral contraceptive pill (COC) consisting of drospirenone 3 mg/ethinyl estradiol 20 µg (3 mg DRSP/20 &
Gloria Bachmann, Sharon Kopacz
doaj  

Home - About - Disclaimer - Privacy